{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:52:59Z","timestamp":1780462379984,"version":"3.54.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,6]],"date-time":"2021-03-06T00:00:00Z","timestamp":1614988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/igo\/"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2018ZX09734004"],"award-info":[{"award-number":["2018ZX09734004"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Western Pacific"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.lanwpc.2021.100133","type":"journal-article","created":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T11:56:36Z","timestamp":1618833396000},"page":"100133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Immunogenicity of two-dose and three-dose vaccination schedules with Sabin inactivated poliovirus vaccine in China: An open-label, randomized, controlled trial"],"prefix":"10.1016","volume":"10","author":[{"given":"Yamin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishali","family":"Jeyaseelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifang","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Mach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance","family":"Rodewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changgui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zundong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijian","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiqiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijie","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanwpc.2021.100133_bib0001","unstructured":"Cases of Wild Poliovirus by Country and Year. Available at: http:\/\/www.polioeradication.org\/Dataandmonitoring\/Poliothisweek\/Wildpolioviruslist.aspx. (Accessed June 03 2020)."},{"issue":"11","key":"10.1016\/j.lanwpc.2021.100133_bib0002","doi-asserted-by":"crossref","first-page":"172","DOI":"10.46234\/ccdcw2020.045","article-title":"Detection and initial response to a Type 2 vaccine-derived poliovirus \u2014 Sichuan Province, China, 2019","volume":"2","author":"Zhou","year":"2020","journal-title":"China CDC Wkly"},{"key":"10.1016\/j.lanwpc.2021.100133_bib0003","unstructured":"Centers for Disease C. Global Certification of Eradication of Indigenous Wild Poliovirus Type 3. Available at: https:\/\/www.cdc.gov\/globalhealth\/immunization\/stories\/global-certification-of-eradication-of-indigenous-wild-poliovirus-type-3.html. (Accessed June 03 2020,)"},{"key":"10.1016\/j.lanwpc.2021.100133_bib0004","doi-asserted-by":"crossref","DOI":"10.1126\/science.aba1238","article-title":"Evolving epidemiology of poliovirus serotype 2 following withdrawal of the type 2 oral poliovirus vaccine","author":"Macklin","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.lanwpc.2021.100133_bib0005","unstructured":"Global polio eradication initiative applauds WHO African region for wild polio-free certification. Available at: http:\/\/polioeradication.org\/news-post\/global-polio-eradication-initiative-applauds-who-african-region-for-wild-polio-free-certification\/. Accessed 20\/10\/2020."},{"key":"10.1016\/j.lanwpc.2021.100133_bib0006","unstructured":"GPEI. Polio Endgame Strategy 2019-2023. Available at: http:\/\/polioeradication.org\/who-we-are\/polio-endgame-strategy-2019-2023\/. (Accessed June 03 2020)."},{"issue":"Suppl 1","key":"10.1016\/j.lanwpc.2021.100133_bib0007","doi-asserted-by":"crossref","first-page":"S434","DOI":"10.1093\/infdis\/jiu222","article-title":"The new polio eradication end game: rationale and supporting evidence","volume":"210","author":"Sutter","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lanwpc.2021.100133_bib0008","doi-asserted-by":"crossref","first-page":"589","DOI":"10.4155\/ppa.12.70","article-title":"Innovative IPV from attenuated Sabin poliovirus or newly designed alternative seed strains","volume":"1","author":"Hamidi","year":"2012","journal-title":"Pharm Pat Anal"},{"key":"10.1016\/j.lanwpc.2021.100133_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(19)30738-8","article-title":"Immunogenicity of three sequential schedules with Sabin inactivated poliovirus vaccine and bivalent oral poliovirus vaccine in Zhejiang, China: an open-label, randomised, controlled trial","author":"He","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanwpc.2021.100133_bib0010","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/infdis\/jiy736","article-title":"Immunogenicity and safety of a sabin strain-based inactivated polio vaccine: a phase 3 clinical trial","volume":"220","author":"Hu","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lanwpc.2021.100133_bib0011","doi-asserted-by":"crossref","first-page":"ofz380","DOI":"10.1093\/ofid\/ofz380","volume":"6","author":"Hu","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.lanwpc.2021.100133_bib0012","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/jpids\/piv017","article-title":"Immunogenicity of two different sequential schedules of inactivated polio vaccine followed by oral polio vaccine versus oral polio vaccine alone in healthy infants in China","volume":"5","author":"Li","year":"2016","journal-title":"J Pediatr Infect Dis Soc"},{"key":"10.1016\/j.lanwpc.2021.100133_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2019.113785","article-title":"Universal ELISA for quantification of d-antigen in inactivated poliovirus vaccines","volume":"276","author":"Kouiavskaia","year":"2020","journal-title":"J Virol Methods"},{"key":"10.1016\/j.lanwpc.2021.100133_bib0014","series-title":"Vaccines","first-page":"573","article-title":"27 - Poliovirus vaccine\u2014Inactivated","author":"Vidor","year":"2013"},{"key":"10.1016\/j.lanwpc.2021.100133_bib0015","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-4939-3292-4_8","article-title":"Standardized methods for detection of poliovirus antibodies","volume":"1387","author":"Weldon","year":"2016","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.lanwpc.2021.100133_bib0016","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1093\/cid\/ciy649","article-title":"Impact of maternal antibody on the immunogenicity of inactivated polio vaccine in infants immunized with bivalent oral polio vaccine: implications for the polio eradication endgame","volume":"67","author":"Gaensbauer","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanwpc.2021.100133_bib0017","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/S0140-6736(15)00237-8","article-title":"Immunogenicity of a new routine vaccination schedule for global poliomyelitis prevention: an open-label, randomised controlled trial","volume":"386","author":"Sutter","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.lanwpc.2021.100133_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002599","article-title":"Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge","volume":"8","author":"Hird","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.lanwpc.2021.100133_bib0019","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S1473-3099(11)70190-6","article-title":"Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: a community-based, randomised controlled trial","volume":"12","author":"Estivariz","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanwpc.2021.100133_bib0020","unstructured":"Sabin IPV package insert. Available at: https:\/\/www.imbcams.ac.cn\/Item\/23096.aspx (Accessed Febuary 20 2021)."}],"container-title":["The Lancet Regional Health - Western Pacific"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606521000420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606521000420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:35:14Z","timestamp":1763001314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666606521000420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":20,"alternative-id":["S2666606521000420"],"URL":"https:\/\/doi.org\/10.1016\/j.lanwpc.2021.100133","relation":{},"ISSN":["2666-6065"],"issn-type":[{"value":"2666-6065","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity of two-dose and three-dose vaccination schedules with Sabin inactivated poliovirus vaccine in China: An open-label, randomized, controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Western Pacific","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanwpc.2021.100133","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100133"}}